Skip to main content

william cooper Archives

Immunosuppressive drugs unlikely to raise fetal risk: study

Nov. 14, 2013—Women with chronic autoimmune diseases who take immunosuppressive medications during their first trimester of pregnancy are not putting their babies at significantly increased risk of adverse outcomes, according to a Vanderbilt study released online by the journal Arthritis and Rheumatism.

Read more


Antipsychotic drug use in children for mood/behavior disorders increases type 2 diabetes risk

Aug. 22, 2013—Prescribing “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows.

Read more


Endowed chair celebration honors nine Vanderbilt faculty

Jan. 21, 2013—The extraordinary academic achievements of nine Vanderbilt University endowed chair holders were recognized during a Jan. 17 ceremony at the Student Life Center.

Read more


MPH Global Health track addresses emerging needs

Jan. 10, 2013—Vanderbilt University is working to train a health care workforce that will be more integrated and team-oriented than ever before. One of the educational programs addressing new needs is the Vanderbilt Master of Public Health (MPH) Program, which launched a new track in Global Health last year.

Read more


Vanderbilt study finds no heart risk in ADHD medications

Nov. 2, 2011—Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more